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Summary
Objective: To generate hypotheses regarding the associations between knee cartilage defects and knee radiographic osteoarthritis (ROA),
cartilage volume, bone size and type II collagen breakdown in adults.
Methods: A cross-sectional convenience sample of 372 male and female subjects (mean age 45 years, range 26e61) was studied. Knee
cartilage defect score (0e4) and prevalence (a defect score of R2), cartilage volume, and bone surface area were determined using T1-
weighted fat saturation MRI. Urinary levels of C-terminal crosslinking telopeptide of type II collagen (U-CTX-II) were measured by enzyme-
linked immunosorbent assay. Height, weight and ROA were measured by standard protocols.
Results: In multivariate analysis, the severity and prevalence of knee cartilage defects were signiﬁcantly and independently associated with
tibiofemoral osteophytes (regression coefﬁcient (b): C0.86 to C1.31/unit, odds ratio (OR): 2.97e3.68/unit, all P! 0.05 with the exception of
OR in lateral tibiofemoral compartment) and tibial bone area (b: C0.11 to C0.25/cm2; OR: 1.33e1.58/cm2, all P! 0.01). Knee cartilage
defects were inconsistently associated with joint space narrowing after adjustment for osteophytes but consistently with knee cartilage volume
(b: 0.27 to 0.70/ml; OR: 0.16e0.56/ml, all P! 0.01 except for OR at lateral tibial cartilage site PZ 0.06). Lastly, knee cartilage defect
severity was signiﬁcantly associated with U-CTX-II (Partial rZC0.18, P! 0.001 for total cartilage defect score).
Conclusion: Osteophytes and increasing knee bone size may be causally related to knee cartilage defects. Furthermore, knee cartilage
defects may result in increased cartilage breakdown leading to decreased cartilage volume and joint space narrowing suggesting an important
role for knee cartilage defects in early knee OA.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) frequently affects the knee and is
characterized by cartilage ﬁssuring and erosion, osteo-
phytes, subchondral sclerosis and cysts in later stages1.
Knee cartilage defects are commonly found by arthroscopy
in symptomatic subjects2 where they are thought to be
largely traumatic3 but little is known about their causes or
natural history. They may increase OA risk but there are
limited data to support this. Preliminary studies have
reported that knee cartilage defects are associated with
KellgreneLawrence score in patients with advanced OA4
and osteophytes in subjects with chronic knee pain5. The
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OA is unclear.
Measurement of joint space narrowing on weight-bearing
plain radiographs represents a simple technique to assess
the severity of chondropathy; however, it is indirect and mild,
moderate and deep cartilage defects of the knee are likely to
remain undetected on radiographs6,7. Magnetic resonance
imaging (MRI) can visualize joint structure directly and non-
invasively, and is recognized as a valid, accurate and
reproducible tool to measure articular cartilage defects8e10,
knee cartilage volume and bone surface area11e15. Knee
cartilage volume16e19, tibial bone area19 and urinary levels
of C-terminal crosslinking telopeptide of type II collagen (U-
CTX-II) as a marker of cartilage breakdown20 have been
reported to be associated with knee radiographic OA (ROA),
but the associations between knee cartilage defects and
cartilage volume, tibial bone area and type II collagen
breakdown are unclear. The aim of this study, therefore, was
to generate hypotheses regarding the association of knee
cartilage defects with early ROA, cartilage volume, bone
size and type II collagen breakdown in a convenience
sample of adult males and females.98
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SUBJECTS
The study was carried out in Southern Tasmania primarily
in the capital city of Hobart from June 2000 until December
2001. It was approved by the Southern Tasmanian Health
and Medical Human Research Ethics Committee and all
subjects provided informed written consent.
A convenience sample was utilized for this study.
Subjects were selected from two sources with different
family histories of OA. Half of the subjects were the adult
children of subjects who had a knee replacement performed
for primary knee OA at any Hobart hospital in the years
1996e2000. This diagnosis was conﬁrmed by reference to
the medical records of the orthopedic surgeon and the
original radiograph where possible. The other half were
randomly selected controls. These were selected by
computer generated random numbers from the most recent
version of the electoral roll (2000). Subjects from either
group were excluded on the basis of contraindication to
magnetic resonance imaging (MRI) (including metal su-
tures, presence of shrapnel, iron ﬁling in eye and
claustrophobia). No women were on hormone replacement
therapy at the time of the study.
ANTHROPOMETRICS
Weight was measured to the nearest 0.1 kg (with shoes,
socks and bulky clothing removed) using a single pair of
electronic scales (Seca Delta Model 707) which were
calibrated using a known weight at the beginning of each
clinic. Height was measured to the nearest 0.1 cm (with
shoes and socks removed) using a stadiometer. Body mass
index (BMI) (kg/m2) was calculated. Knee pain was
determined by self-administered questionnaire if subjects
answered yes to the following question: Have you had knee
pain for more than 24 h in the last 12 months or daily pain
on greater than 30 days in the last year?
X RAY
A standing AP semiﬂexed view of the right knee was
performed in all subjects. Radiographs were then assessed
utilizing the Altman atlas21. Each of the following was
assessed: medial joint space narrowing (0e3), lateral joint
space narrowing (0e3), medial osteophytes (femoral and
tibial combined) (0e3) and lateral osteophytes (femoral and
tibial combined) (0e3). Each score was arrived at by
consensus with two readers (GJ, FS) simultaneously
assessing the radiograph with immediate reference to the
atlas. Reproducibility was assessed and yielded an intra-
class correlation coefﬁcient (ICC) of 0.99 for osteophytes
and 0.98 for joint space narrowing14,19.
KNEE CARTILAGE VOLUME MEASUREMENT
An MRI scan of the right knee was performed. Knee
cartilage volume was determined by means of image
processing on an independent work station using the
software program Osiris as previously described11e15.
Knees were imaged in the sagittal plane on a 1.5-T whole
body magnetic resonance unit (Picker) with use of
a commercial transmitereceive extremity coil. The following
image sequence was used: a T1-weighted fat saturation
three-dimensional (3D) gradient recall acquisition in the
steady state; ﬂip angle 55(; repetition time 58 ms; echo time12 ms; ﬁeld of view 16 cm; 60 partitions; 512! 512 matrix;
acquisition time 11 min 56 s; one acquisition. Sagittal
images were obtained at a partition thickness of 1.5 mm
and an in-plane resolution of 0.31! 0.31 (512! 512
pixels). The image data were transferred to the workstation.
The volumes of individual cartilage plates (medial tibial,
lateral tibial and patella) were isolated from the total volume
by manually drawing disarticulation contours around the
cartilage boundaries on a section by section basis. These
data were then resampled by means of bilinear and cubic
interpolation (area of 312 and 312 mm and 1.5 mm
thickness, continuous sections) for the ﬁnal 3D rendering.
The volume of the particular cartilage plate was then
determined by summing all the pertinent voxels within the
resultant binary volume. Femoral cartilage volume was not
assessed as we have published that two tibial sites and the
patella site correlate strongly with this site (16). Using this
method we had high intra- and interobserver reproducibility.
The coefﬁcient of variation (CV) for cartilage volume
measures was 2.1% for medial tibial, 2.2% for lateral tibial
and 2.6% for patella11.
CARTILAGE DEFECTS ASSESSMENT
The cartilage defects were graded on the above magnetic
resonance (MR) images with a modiﬁcation of a previous
classiﬁcation system8e10 at medial tibial, medial femoral,
lateral tibial, lateral femoral and patellar sites as follows
(Fig. 1): grade 0, normal cartilage; grade 1, focal blistering
and intracartilaginous low-signal intensity area with an
intact surface and base; grade 2, irregularities on the
surface or base and loss of thickness of less than 50%;
grade 3, deep ulceration with loss of thickness of more than
50%; grade 4, full-thickness chondral wear with exposure of
subchondral bone. We found that cartilage surface in some
images was still regular but cartilage adjacent to subchon-
dral bone became irregular, so we included these changes
in the classiﬁcation system. A cartilage defect also had to
be present in at least two consecutive slices. The cartilage
was considered to be normal if the band of intermediate
signal intensity had a uniform thickness. The cartilage
defects were re-graded 1 month later and the average
scores of cartilage defects at medial tibiofemoral (0e8),
lateral tibiofemoral (0e8), patellar (0e4) and whole com-
partments (0e20) were used in the study. A prevalent
cartilage defect was deﬁned as a cartilage defect score of
R2 at any site within that compartment. Intraobserver
reliability (expressed as ICC) was 0.90 for the medial
tibiofemoral compartment, 0.89 for the lateral tibiofemoral
compartment, 0.94 for the patellar compartment and 0.94
for the total score. Interobserver reliability was assessed in
50 MR images and yielded an ICC of 0.90 for the medial
tibiofemoral compartment, 0.85 for the lateral tibiofemoral
compartment, 0.93 for the patellar compartment and 0.93
for the total score.
KNEE BONE SIZE MEASUREMENT
Knee tibial plateau bone area and patellar bone volume
were determined as previously described11e15,19 with CVs
in our hands of 2.2e2.6%11.
U-CTX-II MEASUREMENT
Overnight urine samples were collected in plastic contain-
ers. After mixing the whole collection, aliquots of urine were
200 C. Ding et al.: Knee cartilage defects, early ROA, cartilage loss and bone areaFig. 1. Sagittal T1-weighted fat saturated 3D MRI images shows: (A) Normal lateral tibial, lateral femoral and patellar cartilage (grade 0). (B)
Slight cartilage defects at lateral tibial and patellar site (grade 1) but moderate cartilage defects at lateral femoral site (grade 2). (C) Normal
cartilage at patellar site (grade 0) but severe cartilage defects at lateral tibial and femoral sites (grade 3). (D) Severe cartilage defects at medial
tibial (grade 4) and femoral (grade 3) sites.transferred into plastic tubes and frozen at 70(C without
any acidiﬁcation. U-CTX-II was measured by an enzyme-
linked immunosorbent assay based on a monoclonal
antibody raised against the EKGPDP linear six amino acid
epitope of the type II collagen C-telopeptide (Cartilaps,
Nordic Biosciences, Herlev, Denmark). Intra- and inter-
assay CVs are lower than 8% and 10%20,22.
STATISTICS
t test or ManneWhitney U test (where appropriate) were
used to compare means. Linear regression analysis was
used to examine the associations between knee cartilage
defects, ROA, cartilage volume and bone size before and
after adjustment for age, sex, BMI, family history, cartilage
volume if bone size and bone size if cartilage volume. Forcartilage defect scores in individual compartments the
range and distribution were such that basic assumptions
for applying linear regression did not hold. However, for the
combined total score the assumptions did hold. For the
sake of comparability we used linear regression to assess
multivariable effects adjusting for other covariates for all
score and total score variables. This seemed preferable to
using an ordinal logistic regression model for a pooled
score outcome and linear regression for total score. Logistic
regression analysis was used to examine the associations
between knee cartilage defect prevalence and other
variables. U-CTX-II levels were not normally distributed
(P! 0.001) and were log transformed for all analyses.
Linear regression analysis was also used to examine the
association between cartilage defect score and log trans-
formed U-CTX-II. A P value less than 0.05 (two-tailed) or
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was regarded as statistically signiﬁcant. All statistical
analyses were performed on SPSS version 10.0 for
Windows (Chicago, IL).
Results
A total of 372 subjects (female 214, male 158) aged
between 26 and 61 (mean 45 years) took part. Knee
cartilage defects were common (44%) and varied in severity
from grade 2e4 whereas ROA was uncommon (17%) and
was predominantly grade 1. Demographic and study factors
are presented in Table I. The prevalence of pain was 35%.
In unadjusted analysis, subjects with and without knee
cartilage defects were similar in terms of height, sex
distribution, past knee injury history, tibial cartilage volume,
patellar bone volume and U-CTX-II levels, but subjects with
knee cartilage defects were older, and had higher weight,
BMI, ROA prevalence, and tibial bone area but lower
patellar cartilage volume.
Tables II and III document the associations between
knee cartilage defect, joint space narrowing and cartilage
volume. Knee cartilage defect scores and prevalence were
signiﬁcantly associated with joint space narrowing in tibiofe-
moral compartments both before and after adjustment for
age, sex, BMI and family history. After further adjustment
for osteophytes, these associations decreased by 35e60%
for severity and became non-signiﬁcant for prevalence in all
compartments. Knee cartilage defect scores and preva-
lence were not associated with tibial cartilage volume, but
were signiﬁcantly associated with patellar cartilage volume
in univariate analysis; however, knee cartilage defects in
each compartment were signiﬁcantly negatively associated
with knee cartilage volume after adjustment for age, sex,
BMI, family history and bone size. Similar results were
obtained if subjects with ROA were excluded or men and
women were analyzed separately (data not shown).
Tables IV and V document the associations between
knee cartilage defects, osteophytes and bone size. Knee
cartilage defect scores and prevalence were signiﬁcantlyassociated with osteophytes in tibiofemoral compartments
before and after adjustment for age, sex, BMI and family
history. After further adjustment for joint space narrowing,
these associations decreased by 7e12% for scores and
remained signiﬁcant for scores and prevalence except for
prevalence in the lateral tibiofemoral compartment. Knee
cartilage defect scores and prevalence were signiﬁcantly
associated with tibial bone area, but not patellar bone
volume in univariate analysis. These associations remained
signiﬁcant for tibial bone area and became signiﬁcant for
patellar bone volume after adjustment for age, sex, BMI,
family history and cartilage volume. Similar results were
obtained if subjects with ROA were excluded or men and
women were analyzed separately (data not shown). Knee
cartilage defect severity in all compartments was signiﬁ-
cantly associated with U-CTX-II in total sample and women,
but not in men (Fig. 2). These associations in total sample
remained signiﬁcant or of borderline signiﬁcance after
adjustment for age, sex, BMI and family history (Partial
rZC0.18, PZ 0.001 for total cartilage defect score;
Partial rZC0.08, PZ 0.11 for medial tibiofemoral carti-
lage defect score; Partial rZC0.10, PZ 0.055 for lateral
tibiofemoral cartilage defect score; Partial rZC0.18,
PZ 0.001 for patellar cartilage defect score). Prevalent
knee cartilage defects were not signiﬁcantly associated with
U-CTX-II with the exception of prevalent patellar cartilage
defects (PZ 0.048).
Discussion
In this convenience sample of males and females, the
severity and prevalence of knee cartilage defects were
signiﬁcantly associated with early knee ROA especially
osteophytes and, to a lesser extent, joint space narrowing.
They also were signiﬁcantly positively associated with knee
bone size and negatively associated with knee cartilage
volume in all compartments. Furthermore, knee cartilage
defect severity was associated with increased type II
collagen breakdown.Table I
Characteristics of participants
No cartilage
defects, NZ 210
Any cartilage
defects, NZ 162
P Value
Age (years) 43.6 (7.1) 47.0 (6.1) !0.01
Height (cm) 168.7 (8.0) 169.6 (9.0) 0.31
Weight (kg) 74.7 (13.8) 81.2 (16.6) !0.01
BMI 26.2 (4.2) 28.2 (5.0) !0.01
Male: female ratio 58% female 57% female 0.97*
Past knee injury (%) 18 21 0.49*
Any knee radiographic change (%) 10 26 !0.01*
Medial joint space narrowing (%) 9 20 !0.01*
Lateral joint space narrowing (%) 1 6 0.02*
Medial osteophytes (%) 2 13 !0.01*
Lateral osteophytes (%) 1 6 0.07*
Medial tibial cartilage volume (ml) 2.3 (0.6) 2.2 (0.6) 0.30
Lateral tibial cartilage volume (ml) 2.6 (0.6) 2.6 (0.7) 0.49
Patella cartilage volume (ml) 3.7 (0.9) 17.9 (2.9) !0.01
Lateral tibial bone area (cm2) 11.7 (1.8) 12.3 (2.2) !0.01
Patella bone volume (ml) 13.7 (3.3) 13.9 (3.4) 0.72
ln U-CTX-II 4.8 (0.6) 4.9 (0.5) 0.52
Mean (SD) except for percentages.
U-CTX-II: Urinary C-terminal crosslinking telopeptide of type II collagen.
*ManneWhitney U test, all others unpaired t test.
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The associations between knee cartilage defect severity, joint space narrowing and cartilage volume
Univariate b (95% CI) Multivariate* b (95% CI) Multivariatey b (95% CI)
MTF cartilage defectsz
MTF JSN (per grade) D0.61 (D0.39, D0.82) D0.55 (D0.34, D0.76) D0.36 (D0.15, D0.57)
MT cartilage volume (per ml) 0.12 (0.25, C0.01) 0.31 (0.46, 0.16) 0.45 (0.61, 0.30)
LTF cartilage defectsz
LTF JSN (per grade) D0.87 (D0.50, D1.24) D0.86 (D0.49, D1.22) C0.34 (0.02, C0.70)
LT cartilage volume (per ml) C0.08 (0.03, C0.20) 0.08 (0.22, C0.06) 0.26 (0.42, 0.11)
Patellar cartilage defectsz
PAT cartilage volume (per ml) 0.50 (0.59, 0.41) 0.60 (0.71, 0.49) 0.68 (0.80, 0.57)
Total cartilage defectsz
TF JSN (per grade) D0.99 (D0.58, D1.41) D0.73 (D0.33, D1.13) D0.43 (D0.04, D0.83)
Total cartilage volume (per ml) 0.18 (0.28, 0.09) 0.36 (0.47, 0.24) 0.55 (0.67, 0.44)
*Adjusted for age, gender, BMI and family history.
yAdjusted by previous factors and bone size if cartilage volume or osteophytes if joint space narrowing.
zDependent variables. MTF: medial tibiofemoral; LTF: lateral tibiofemoral; JSN: joint space narrowing; MT: medial tibial; LT: lateral tibial;
PAT: patellar; TF: tibiofemoral.Knee cartilage defects can occur through injury and
trauma3 and may predispose patients to radiographic
change and clinical symptoms of knee OA. A recent study
reported knee cartilage defects were frequently demon-
strated on MRI in patients with advanced ROA but it is
uncertain whether these cartilage defects lead to OA or
more severe arthritis results in increased cartilage dam-
age4. Furthermore, the association between knee cartilage
defects and early ROA has not yet been reported. In the
current sample, ROA was uncommon and was predomi-
nantly mild. However, knee cartilage defects were common
and of varying severity, and were signiﬁcantly associated
with both early ROA and decreased cartilage volume. The
causal direction of association is unclear from this cross-
sectional study. Biologically, it would make sense to infer
that osteophytes lead to cartilage defects through increased
force transmission and that cartilage defects lead to joint
space narrowing through increased cartilage loss. Our data
on the association between cartilage defects and both
cartilage volume and U-CTX-II are consistent with this
explanation. Nevertheless, longitudinal studies will be
required to more fully delineate causal directions.Subchondral bone may have an important role to play in
the initiation and progression of cartilage damage23e25.
Previous studies have shown that knee cartilage defects on
MRI were signiﬁcantly associated with osteophytes on
radiographs of the same joint5, and that the presence of
subchondral bone abnormalities and bone marrow edema
on MRI at baseline predicted worsening of cartilage defects
after 1 year9. We recently reported that there was a sub-
stantial 10e22% increase in lateral and medial tibial bone
areas with grade 1 osteophytosis, but not with grade 1 joint
space narrowing19. In the current study, the severity and
prevalence of knee cartilage defects were signiﬁcantly
associated with osteophytes and bone size. These results
were consistent in all compartments even though patellar
bone size and tibial bone size were measured in different
ways, supporting a role of subchondral bone expansion in
the etiology of knee cartilage defects, particularly given that
our grading scale included defects that were deep and thus
adjacent to subchondral bone. The associations between
cartilage defects and osteophytes or bone area were
stronger than those between cartilage defects and joint
space narrowing or cartilage volume, and the associationsTable III
The associations between knee cartilage defect prevalence, joint space narrowing and cartilage volume
Univariate OR (95% CI) Multivariate* OR (95% CI) Multivariatey OR (95% CI)
Prevalent MTF defectz
MTF JSN (per grade) 3.40 (1.76e6.57) 2.98 (1.44e6.18) 2.20 (1.00e4.87)
MT cartilage volume (per ml) 0.66 (0.40e1.09) 0.31 (0.16e0.61) 0.16 (0.07e0.36)
Prevalent LTF defectz
LTF JSN (per grade) 3.18 (1.12e9.05) 3.11 (1.00e9.64) 2.40 (0.68e8.48)
LT cartilage volume (per ml) 1.18 (0.80e1.72) 0.81 (0.49e1.35) 0.59 (0.33e1.06)
Prevalent patellar defectz
PAT cartilage volume (per ml) 0.33 (0.24e0.45) 0.27 (0.18e0.41) 0.20 (0.13e0.32)
Prevalent any defectz
TF JSN (per grade) 2.42 (1.44e4.07) 2.03 (1.16e3.53) 1.76 (1.00e3.09)
Total cartilage volume (per ml) 0.86 (0.77e0.95) 0.73 (0.62e0.86) 0.56 (0.45e0.68)
*Adjusted for age, gender, BMI and family history.
yAdjusted by previous factors and bone size if cartilage volume or by osteophytes if joint space narrowing.
zDependent variables. MTF: medial tibiofemoral; LTF: lateral tibiofemoral; JSN: joint space narrowing; MT: medial tibial; LT: lateral tibial;
PAT: patellar; TF: tibiofemoral.
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The associations between knee cartilage defect severity, osteophytes and bone size
Univariate b (95%CI) Multivariate* b (95% CI) Multivariatey b (95% CI)
MTF cartilage defectsz
MTF osteophytes (per grade) D1.11 (D0.85, D1.36) D0.98 (D0.73, D1.23) D0.86 (D0.60, D1.12)
MT bone area (per cm2) D0.06 (D0.03, D0.09) D0.06 (D0.03, D0.10) D0.11 (D0.07, D0.15)
LTF cartilage defectsz
LTF osteophytes (per grade) D1.39 (D1.10, D1.68) D1.30 (D1.02, D1.59) D1.20 (D0.90, D1.50)
LT bone area (per cm2) D0.13 (D0.09, D0.16) D0.13 (D0.08, D0.18) D0.17 (D0.11, D0.22)
Patellar cartilage defectsz
PAT bone volume (per ml) 0.02 (0.05, C0.01) C0.02 (0.03, C0.06) D0.08 (D0.05, D0.12)
Total cartilage defectsz
TF osteophytes (per grade) D1.65 (D1.24, D2.06) D1.41 (D1.02, D1.81) D1.31 (D0.91, D1.71)
Total tibial bone area (per cm2) D0.09 (D0.05, D0.13) D0.13 (D0.07, D0.19) D0.25 (D0.19, D0.31)
*Adjusted for age, gender, BMI and family history.
yAdjusted for previous factors and joint space narrowing if osteophytes or cartilage volume if bone size.
zDependent variables. MTF: medial tibiofemoral; LTF: lateral tibiofemoral; MT: medial tibial; LT: lateral tibial; PAT: patellar; TF: tibiofemoral.between knee cartilage defects and osteophytes changed
little after adjustment for joint space narrowing, but the
associations between knee cartilage defects and joint
space narrowing decreased markedly after adjustment for
osteophytes, suggesting subchondral bone changes with
cartilage defects are primary, and subchondral bone
change precedes cartilage damage in early knee OA.
Type II collagen is a major structural component of
cartilage and is localized almost exclusively in this tissue.
Hence, measurements of fragments derived from this
protein such as U-CTX-II may potentially represent a spe-
ciﬁc index for cartilage breakdown. The U-CTX-II assay has
showed high technical precision and ability to differentiate
populations with an elevated joint metabolism from normal
controls22. U-CTX-II levels are signiﬁcantly raised20,22 and
associated with knee joint space width and area in
established knee OA20 and a recent report found the
increased levels were signiﬁcantly associated with the
progression of chondropathy by arthroscopy after 1 year
follow-up26. In the current sample with early knee ROA, we
failed to ﬁnd any association between U-CTX-II levels and
joint space narrowing (data not shown); however, knee
cartilage defect severity in all compartments measured byMRI was positively associated with U-CTX-II levels. These
ﬁndings are in agreement with biochemical and histological
studies indicating that type II collagen degradation is an
early sign of cartilage damage27,28. The strength of
association was modest but strongest for the total knee
which is perhaps not surprising given that CTX-II comes
from hyaline cartilage throughout the body and one knee
only makes a small contribution to total hyaline cartilage.
The association was signiﬁcant in women but not in men.
The reason for this is unclear but may suggest that women
have greater susceptibility to cartilage defects, or may
reﬂect a greater contribution to U-CTX-II from sites outside
the knee in males due to their larger body size.
This study has a number of limitations. Firstly, the study
was primarily designed to look at genetic mechanisms of
knee OA and utilized a matched design. The matching was
broken for the current study but adjustment for family history
did not alter the results. Indeed, while there was a reduction
in power, the results otherwise did not differ if examined in
offspring and controls separately. While the sample is
a convenience sample, Miettinen29 states that for these
associations to be generalizable to other populations three
key criteria need to be met regarding selection, sampleTable V
The associations between knee cartilage defect prevalence, osteophytes and bone size
Univariate OR (95% CI) Multivariate* OR 95% CI) Multivariatey OR 95% CI)
Prevalent MTF defectz
MTF osteophytes (per grade) 6.78 (2.85e16.09) 4.65 (1.88e11.49) 3.68 (1.45e9.33)
MT bone area (per cm2) 1.22 (1.10e1.35) 1.29 (1.10e1.51) 1.58(1.30e1.91)
Prevalent LTF defectz
LTF osteophytes (per grade) 3.77 (1.28e11.07) 3.18 (1.04e9.71) 2.75 (0.81e9.34)
LT bone area (per cm2) 1.26 (1.11e1.44) 1.24 (1.03e1.50) 1.33 (1.09e1.63)
Prevalent patellar defectz
PAT bone volume (per ml) 0.98 (0.91e1.05) 1.10 (0.99e1.22) 1.28 (1.14e1.45)
Prevalent any defectz
TF osteophytes (per grade) 4.23 (1.70e10.48) 3.45 (1.35e8.82) 2.97 (1.16e7.61)
Total tibial bone area (per cm2) 1.07 (1.02e1.13) 1.15 (1.06e1.25) 1.33 (1.20e1.48)
*Adjusted for age, gender, BMI and family history.
yAdjusted for previous factors and joint space narrowing if osteophytes or cartilage volume if bone size.
zDependent variables. MTF: medial tibiofemoral; LTF: lateral tibiofemoral; MT: medial tibial; LT: lateral tibial; PAT: patellar; TF: tibiofemoral.
204 C. Ding et al.: Knee cartilage defects, early ROA, cartilage loss and bone areaFig. 2. Correlation between knee cartilage defects and U-CTX-II. There were signiﬁcant positive associations between CTX-II and knee
cartilage defect severity in all compartments in total sample and women, but not men. T: total sample; F: females; M: males.size and adequate distribution of study factors all of
which are met by this study. Secondly, measurement error
may inﬂuence results. However, knee cartilage defects
scoring, cartilage volume, bone size, ROA and CTX-II
measurement11e15,20,22 were all highly reproducible sug-
gesting that this is unlikely.
In conclusion, this cross-sectional study suggests osteo-
phytes and increasing knee bone size may be causally
related to knee cartilage defects. Furthermore, knee
cartilage defects may result in increased cartilage break-
down leading to decreased cartilage volume and joint spacenarrowing suggesting an important role for knee cartilage
defects in early knee OA.
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